PPT-Management of Hepatocellular Carcinoma (HCC) during Covid-19
Author : samantha | Published Date : 2023-11-20
Mark Sonderup and Douglas LaBrecque Division of Hepatology Department of Medicine University of Cape Town and Groote Schuur Hospital Cape Town South Africa Emeritus
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Management of Hepatocellular Carcinoma ..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Management of Hepatocellular Carcinoma (HCC) during Covid-19: Transcript
Mark Sonderup and Douglas LaBrecque Division of Hepatology Department of Medicine University of Cape Town and Groote Schuur Hospital Cape Town South Africa Emeritus Professor of Internal Medicine Gastroenterology and Hepatology. Erin Alesi, MD. Medical Oncology and Palliative Medicine. Objectives. Review anatomy of the nasopharynx. Discuss epidemiology of nasopharyngeal (NP) carcinoma. Discuss etiology and risk factors. Review histology. risk factors and pathogenesis. Dr Richard Phillips. KNUST/KATH. Introduction. 0.25-1.2 million . cases worldwide per . year. 5. th. most common human cancer. . 80% of burden in developing countries. Authors. : . Federico Piñero. 1,11,12. , Fernando Rubinstein. 15. , . Sebastián. Marciano. 2. , Nora Fernández. 5. , Jorge Silva. 10. , . Yanina. Zambelo. 8. , Margarita Anders. 4. , . Alina. Zerega. Serum Squamous . Cell Carcinoma Antigen (SCCA) for Prediction of HCC Patients . Presented . By:. Sally Saad Mandour Esawy. Ass. . Lecturer of Clinical Pathology. National Liver Institute, . Menoufia. Curtis Barry, MD. UMASS ECHO. April 21, 2017. Ascites. The Development of Ascites. Revised Underfill. . Peripheral vasodilation occurs as the result of decreased hepatic clearance of vasodilators such as glucagon and NO. Trauma/Acute care Surgeon. Beacon Medical Group. 01APR2020. Objective. Provide and understanding of where we are in terms of surgical care today. ACS Committee on Trauma Response. Define the term “Aerosol Generating Procedure”. Presented by:. Dr. . Iram. Naseer. Moderated by:. Prof .. Iqbal. Aziz. . BREAST CARCINOMA. •Breast cancer is most . common. malignancy . in . female. . •Second to lung . cancer. •Now the mortality rate . Strategies for Incorporating Emerging. Immunotherapy Treatment Options . Patient Case 1. 65-year-old, otherwise healthy man with history of HCV. In screening, noted to have a 2.1 cm . hypervascular. estimate that, in 2030, liver cancer will be the thirdleading cause of cancerrelated deaths, surpassing breast, colorectal, and prostate cancers.xivxvAlthough liver cancer remains one of the few cance ● ● CBC with differential , liver function test ( LFTs ) , c reatinine , electrolytes , PT / INR , lipid profile , hemoglobin A 1 C , alpha - fetoprotein ( AFP ) ● Viral serologies if 4874 Key words (MeSH)Carcinoma hepatocellularMagnetic resonance Liver neoplasms Palabras clave (DeCS)Carcinoma hepatocelularImagen por resonancia Neoplasias hepáticas Magnetic Resonance Imaging of th Hepatocellular Carcinoma. Risk factors for HCC. HBV – the most common causative risk factor. Increased risk :. Earlier infection. Higher DNA load (>2000 IU/L). Higher level of quant. . HbsAg. (>10,000 U/L). Berry Campbell, MD. Prisma Health Midlands. UofSC School of Medicine. SMFM Updates June 16, 2020. Management considerations for pregnant patients with Covid 19. Labor and delivery Covid-19 considerations.
Download Document
Here is the link to download the presentation.
"Management of Hepatocellular Carcinoma (HCC) during Covid-19"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents